Representative Kevin Hern (Republican-Oklahoma) recently bought shares of Waters Corporation (NYSE:WAT). In a filing disclosed on March 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on February 9th. The trade occurred in the Representative’s “HERN FAMILY REVOCABLE TRUST” account.
Representative Kevin Hern also recently made the following trade(s):
- Sold $250,001 – $500,000 in shares of UnitedHealth Group (NYSE:UNH) on 12/23/2025.
Waters Price Performance
Shares of WAT stock opened at $302.44 on Friday. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15. The company has a current ratio of 1.73, a quick ratio of 1.27 and a debt-to-equity ratio of 0.37. The firm’s 50 day moving average is $361.44 and its 200-day moving average is $351.27. The firm has a market capitalization of $29.67 billion, a price-to-earnings ratio of 28.08, a PEG ratio of 2.08 and a beta of 1.20.
Hedge Funds Weigh In On Waters
A number of institutional investors and hedge funds have recently added to or reduced their stakes in WAT. Root Financial Partners LLC acquired a new stake in shares of Waters in the 3rd quarter valued at about $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Waters in the 3rd quarter valued at approximately $26,000. Zions Bancorporation National Association UT raised its position in Waters by 121.2% in the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 40 shares during the last quarter. SHP Wealth Management bought a new stake in Waters in the 4th quarter valued at approximately $32,000. Finally, DV Equities LLC acquired a new position in Waters during the 4th quarter worth approximately $32,000. 94.01% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on WAT shares. HSBC assumed coverage on Waters in a research report on Tuesday, January 27th. They set a “buy” rating and a $460.00 target price for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research report on Wednesday, January 21st. Barclays assumed coverage on Waters in a report on Tuesday, February 10th. They set an “overweight” rating and a $400.00 price objective for the company. UBS Group reduced their target price on shares of Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 10th. Finally, Wells Fargo & Company lowered their price target on shares of Waters from $415.00 to $355.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 11th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, Waters presently has an average rating of “Moderate Buy” and an average price target of $393.84.
View Our Latest Stock Report on Waters
About Representative Hern
Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma’s 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027.
Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma’s 1st Congressional District. He declared candidacy for the 2026 election.
Kevin Hern went into business as a McDonald’s franchisee in 1999. He acquired 10 McDonald’s franchises by 2012. He served on the McDonald’s National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.
About Waters
Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.
Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.
Read More
- Five stocks we like better than Waters
- “I just bought 10,000 shares of a $5 stock…”
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Central banks just did something they haven’t done since 1967
- SpaceX IPO Confirmed: Claim Your Stake Today
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
